Home > Insider Trading > Filing (0001127602-21-015775)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1580827	C Eva Boratto	One Cvs Drive Woonsocket RI 02895	Evp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-05-04	4,905	$80.00	115,331	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock (Restricted)	2,242	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$102.26	2016-04-01	2022-04-01	27,392	27,392	Direct
Common Stock	Stock Option	$104.82	2017-04-01	2023-04-01	21,509	21,509	Direct
Common Stock	Stock Option	$78.05	2018-04-03	2024-04-03	35,062	35,062	Direct
Common Stock	Stock Option	$62.21	2019-04-01	2025-04-01	35,030	35,030	Direct
Common Stock	Stock Option	$54.19	2020-04-01	2029-04-01	202,007	202,007	Direct
Common Stock	Stock Option	$58.34	2021-04-01	2030-04-01	168,956	168,956	Direct
Common Stock	Stock Option	$74.30	2022-04-01	2031-04-01	103,663	103,663	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2022-04-01	27,392	27,392	Direct
2023-04-01	21,509	21,509	Direct
2024-04-03	35,062	35,062	Direct
2025-04-01	35,030	35,030	Direct
2029-04-01	202,007	202,007	Direct
2030-04-01	168,956	168,956	Direct
2031-04-01	103,663	103,663	Direct

Footnotes

All sales were effected pursuant to a Rule 10b5-1 plan.
Option became exercisable in four equal annual installments, commencing 4/1/2016.
Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
Option became exercisable in four equal annual installments, commencing 4/3/2018.
Option became exercisable in four equal annual installments, commencing 4/1/2019.
Option became exercisable in four equal annual installments, commencing 4/1/2020.
The number of shares subject to the option were calculated using a 30-day average price.
Options became exercisable in four equal annual installments, commencing 4/1/2021.
Option becomes exercisable in four equal annual installments, commencing 4/1/2022.